Xiangya Hospital, Central South University — Changsha, Hunan

Public research footprint of Xiangya Hospital, Central South University, compiled from the ClinicalTrials.gov public registry.

580

Registered studies

226

Active

130

Recruiting now

198

Completed

Stopped or withdrawn

Most-studied conditions

Non-Small Cell Lung Cancer (NSCLC) · Arthritis, Psoriatic · Limited-stage Small Cell Lung Cancer (LS-SCLC) · Crohn Disease

Recently updated registry entries

NCT07369999 — Effects of Butylphthalide Enhanced With Tenecteplase on Neurological Function in Mild… (Recruiting)
NCT06952504 — A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab… (Recruiting)
NCT07712705 — HPP737 in Adult Patients With Moderate-to-severe Plaque Psoriasis. (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Xiangya Hospital, Central South University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.